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SUMMARY  
Background:  Ceiba pentandra (L.) Gaertn, common-
ly called silk-cotton tree, has been extensively used by 
traditional medicine practitioners in Northern and East-
ern Nigeria in the control and management of diabetes. 
Objective: To evaluate the hypoglycaemic and anti-
hyperglycaemic effect of ethanolic extract of Ceiba 
pentandra bark in normal and streptozotocin induced 
diabetic rats.  
Method: Screening activity of the extract was carried 
out by OGTT. Diabetes mellitus was induced with 
streptozotocin and graded doses of the ethanolic bark 
extract (200 and 400 mg/kg, b.w.) were then adminis-
tered to the experimentally diabetic rats. The blood 
glucose level was measured at different time intervals.  
Results: The single dose study of C. pentandra extract 
at two different doses produced no significant hypogly-
caemic effect in normal rats but C. pentandra (200 
mg/kg) significantly decreased blood glucose level in 
diabetic rats. In OGTT, C. pentandra (200 mg/kg) sig-
nificantly reduced elevated glucose level in normal and 
diabetic rats. In long term (21 days) study, C. pentan-
dra (200 mg/kg) significantly decreased blood glucose 
level, total cholesterol and triglycerides level, prevent-
ed degeneration of liver and pancreas, and increased 
serum insulin level and liver glycogen content in dia-
betic rats. Acute toxicity study in rats did not show any 
signs of toxicity up to the dose of 2000 mg/kg b.w.  
Conclusion: The results reveal that the extract im-
proved glucose tolerance in normal and streptozotocin-
induced diabetic rats. Thus the study suggests that the 
C. pentandra bark extract could be beneficial in the 
management of type I diabetes.  
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Diabetes mellitus is recognized as one of the leading 
causes of morbidity and mortality in the world.  
About 2.5-3% of the world’s population suffers from 
this disease, a proportion which, in some countries, can 
reach 7% or more. Hyperglycemia leads to metabolic 
disorders and various complications.1 According to 
W.H.O projections, the prevalence of diabetes is likely 
to increase by 35%. Currently there are over 150 mil-
lion diabetic people worldwide and this is likely to 
increase to 300 million or more by the year 2025.  
 
Statistical projections about India suggest that the 
number of diabetes will rise from 15 million in 1995 to 
57 million in the year 2025 making it the country with 
the highest number of diabetic people in the world.2,3 
There are more women than men with diabetes, espe-
cially in developed countries. In the future, diabetes 
will be increasingly concentrated in urban areas. In 
modern medicine, the beneficial effects on glycaemic 
levels are well documented; the preventing activity of 
the drugs against progressive nature of diabetes and its 
micro and macrovascular complications was modest 
and not always effective. 
 
 Insulin therapy affords effective glycaemic control, yet 
its short comings such as ineffectiveness on oral ad-
ministration, short shelf life, requirement of constant 
refrigeration, and in the event of excess dosage fatal 
hypoglycaemia limits its usage. Treatment with sul-
fonylureas and biguanides is also associated with side 
effects.4 It is apparent that due to the side effects of the 
currently used drugs, there is a need for safe agents 
with minimal adverse effects, which can be taken for 
long duration. For various reasons in recent years, the 
popularity of complementary medicine has increased.  
 
Dietary measures and traditional plant therapies as pre-
scribed by Ayurvedic and other indigenous systems of 
medicine were used commonly in India.5  
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In the indigenous system of medicine (Ayurveda), a 
number of plants were in practice for the cure of diabe-
tes or ‘Madhumeha’ and some of them have been ex-
perimentally evaluated and the active principles were 
isolated.6,9 However, search for newer antidiabetic 
drugs continues. 
 
Ceiba pentandra (L.) Gaertn, commonly called white 
silk-cotton tree belongs to the family Bombacaceae. It 
is an elegant large tree, found throughout hotter parts 
of India, especially in southern and western India and 
the Andaman Islands. The tree is native to Mexico, 
Central America and the Caribbean, northern South 
America, and to tropical West Africa. It is widely used 
in traditional medicines as a diuretic and an emollient.  
 
Various parts of this plant has been used as demulcent, 
laxative, astringent, emollient, emetic, febrifuge, stimu-
lant, tonic and antispasmodic. Ethno medically, C. pen-
tandra bark decoction has been used as a diuretic, aph-
rodisiac, and to treat headache, as well as type II diabe-
tes.10,11 The leaves, bark, shoots and roots of the plant 
have been used extensively by traditional medicine 
practitioners in Northern and Eastern Nigeria in the 
control and management of diabetes.12-13 
 
There is scientific evidence to support the anti-diabetic 
effect of methylene chloride/methanol root extract of 
C. pentandra in normal and diabetic rats.14-16 The 
chronic hypoglycaemic activity of the stem bark aque-
ous extract of C. pentandra at high doses has been re-
ported.17 A new isoflavone glycoside was isolated 
along with known isoflavones, vavain and vavain glu-
coside from the 80% ethanolic extract of the bark of C. 
pentandra.18  
 
Hence the present study focused to evaluate the hypo-
glycemic and antihyperglycemic activity of ethanolic 
extract of C. pentandra bark at various doses in normal 
and streptozotocin (STZ) induced diabetic rats. Screen-
ing activity of the extract was carried out by type I an-
tidiabetic models which includes Oral Glucose Toler-
ance Test (OGTT) and hypoglycemic effect on normal 
and streptozotocin induced diabetic rats. 
 
MATERIALS AND METHODS 
Plant material and extract preparation 
Bark of Ceiba pentandra (L.) Gaertn was collected in 
the month of June from the large tree grown in the Hor-
ticultural farm of Indian Institute of Horticulture Re-
search  (IIHR), Bangalore. It was identified and au-
thenticated by Dr. T.N. Shivananda, Senior Scientist, 
IIHR, Bangalore, and Prof. Balakrishna Gowda, Head, 
Dept. of Botany, UAS, GKVK, Bangalore.  
 
Shade-dried powdered bark (1000 g) of C. pentandra 
was extracted with alcohol (70% v/v) by soxhletting 
until there was no compound left over in solvent. The 
crude extract was evaporated to dryness at 600C on a 
water bath (15.5% w/w). 
 
Animals 
Adult male Wistar rats weighing 175-200 g were used 
in the present study. Animals were obtained from 
Drugs Testing Laboratory, Palace Road, Bangalore. 
They were acclimatized to the laboratory conditions for 
5 days before experimentation. The animals had free 
access to food and water and were housed under a nat-
ural light-dark cycle. The experiment was carried out 
with the approval of the Institutional Animal Ethics 
Committee (Proposal No. GCP/CPCSEA/2004-05).  
 
Acute toxicity study 
Acute toxicity study was conducted as per Centre for 
Drug Evaluation and Research (CDER), Guidance for 
Industry: Single Dose Acute Toxicity Testing for 
Pharmaceuticals.  
 
To determine acute oral toxicity, different doses of the 
ethanolic bark extract (0.5, 1.0, 1.5, 2 g/kg) suspended 
in 0.5% sodium carboxy methylcellulose (CMC) were 
administered to different groups of rats (2 rats were 
used for each group, control rats received 0.5% sodium 
CMC). Mortality and general behaviour of the animals 
were observed periodically for 48 h. The animals were 
observed continuously for the initial 4 h and intermit-
tently for the next 6 h and then again at 24 h and 48 h 
following drug administration. The parameters ob-
served were grooming, hyperactivity, sedation, loss of 
righting reflex, respiratory rate and convulsion. 
 
Induction of diabetes 
Diabetes was induced by a single intraperitoneal injec-
tion of freshly prepared streptozotocin (STZ) (Sigma-
Aldrich Co., St. Louis, MO, USA.) at the dose of 60 
mg/kg in 0.01 M sodium citrate buffer (pH 4.5) to a 
group of overnight fasted rats.19 After 3 days of strep-
tozotocin administration, depending on their blood 
glucose levels (BGLs) the severe diabetic animals were 
selected for the further study. 
 
Experimental design 
Initial screening of the ethanolic extract of C. pentan-
dra bark for evaluating its glycemic potential was per-
formed with two different doses (200 and 400 mg/kg) 
given orally by gavage in normal rats by conducting 
fasting blood glucose (FBG) test.  
 
The OGTT and antidiabetic effect of the extract was 
also assessed in diabetic models with a dose of 200 
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mg/kg, which was identified as the most effective dose 
by initial screening. 
 
Assessment of hypoglycemic activity in normal 
healthy rats (single dose study) 
Overnight fasted male Wistar rats were divided into 
four groups of six animals each. Group I serving as 
control, received vehicle (0.5% w/v sodium CMC sus-
pension). Group II & III received ethanolic extract 
orally in doses of 200 & 400 mg/kg b.w., respectively. 
Group IV served as reference standard and received 
glibenclamide (1 mg/kg). FBG was recorded initially 
and then blood samples (20 µL) were collected from 
the retroorbital sinus at 30, 60, 90 and 120 min after 
administering the extract. The blood glucose level 
(BGL) was measured by using Electronic Digital Glu-
cometer (Ascensia Entrust Blood Glucose Meter, Bayer 
Diagnostics India Ltd). 
 
Assessment of hypoglycemic activity by Oral Glucose 
Tolerance Test in normal and STZ induced diabetic 
rats 
The oral glucose tolerance test20 was performed in 
overnight fasted normal and diabetic rats. 36 Animals 
were divided into six groups. Group I, II & III were 
orally administered 0.5% w/v sodium CMC suspen-
sion, ethanolic extract of C. pentandra (200 mg/kg) 
and glibenclamide (1 mg/kg), respectively. Diabetic 
groups IV, V & VI were orally administered 0.5% w/v 
sodium CMC suspension, ethanolic extract of C. pen-
tandra (200 mg/kg) and glibenclamide (1 mg/kg), re-
spectively. FBG test was conducted initially and then 
BGL was recorded after 30 min of treatment consid-
ered as 0 min value. A dose of 10 g/kg of glucose was 
then given orally to all the groups. BGLs were further 
recorded, up to two hours at regular interval of 30 min, 
considered as 30, 60, 90 and 120 min values.  
 
Assessment of antidiabetic activity in STZ induced 
diabetic rats (single dose study) 
Overnight fasted diabetic male Wistar rats were divid-
ed into three groups of six animals each. Group I 
served as control received vehicle (0.5% w/v sodium 
CMC suspension). Group II received ethanolic extract 
(200 mg/kg). Group III served as reference standard 
received glibenclamide (1 mg/kg). FBG test was con-
ducted initially and then blood samples were collected 
from the retroorbital sinus at 30, 60, 90 and 120 min 
after oral administration of various treatments.  
 
Assessment of antidiabetic activity in STZ induced 
diabetic rats (repeated dose study) 
Long term study of 21 days was conducted in diabetic 
rats. Overnight fasted diabetic male Wistar rats were 
divided into four groups of six animals each. Group I 
serving as normal control received vehicle (0.5% w/v 
sodium CMC suspension). Group II served as diabetic 
control and received vehicle (0.5% w/v sodium CMC 
suspension).   
 
Animals of Group III received ethanolic bark extract 
(200 mg/kg). Group IV serving as a positive control 
received a dose of 1 mg/kg of a known antidiabetic 
drug, glibenclamide. Blood samples were collected 
from the retro orbital sinus on day 1 and day 21. BGL 
was measured initially and after the treatment period. 
Serum insulin was estimated by the method of radio-
immunoassay (RIA) using Medicorp RIA kit. Total 
cholesterol and triglycerides were estimated from the 
serum samples through Semi auto analyzer of Glaxo 
Qualigens Co., using commercially available direct 
estimation kits from Team Diagnostics Pvt. Ltd. The 
animals were sacrificed by decapitation and the glyco-
gen content of the liver was estimated.21 The histo-
pathological studies were carried out on organs like 
liver and pancreas preserved in 10% formalin immedi-
ately after dissection. 
 
Statistical analysis 
Results were expressed as mean ± SEM. The data was 
evaluated by one-way ANOVA followed by Bonferro-
ni’s multiple comparison tests using GraphPad Prism 
4.0 (GraphPad Software, San Diego, CA, USA). Val-
ues of p<0.05 were considered statistically significant. 
 
RESULTS  
Acute toxicity study 
No toxic effect was observed on treatment up to 2000 
mg/kg of the extract as the behaviour of the treated rats 
appeared normal and no death occurred.  
   
Effect on fasting blood glucose level of normal 
healthy rats (single dose study) 
The effect of different doses of ethanolic extract of C. 
pentandra on fasting blood sugar level of normal rats 
were assessed at different time intervals and depicted 
in Table 1. The BGL at different time intervals (30, 60, 
90 & 120 min) were compared with initial (0 min) 
BGL of their respective groups. In vehicle control 
group there was no significant change in BGL during 
the 2 h study period. There was significant (p<0.001) 
decrease in BGL at different time interval in 
glibenclamide group. The extract treatment groups at 
doses 200 & 400 mg/kg showed significant (p<0.001) 
increase in BGL at 30 min when compared to initial (0 
min) BGL but at 120 min BGL was slightly decreased.  
 
Effect on oral glucose tolerance of normal and STZ 
induced diabetic rats 
Table 2 demonstrates the effect of ethanolic extract of 
C. pentandra on BGL of normal and STZ induced dia-
betic rats during OGTT studies.  
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After 2h of glucose administration the significant 
(p<0.001) decrease in BGL was observed with the ex-
tract treatment (200 mg/kg) and glibenclamide group of 
normal rats when compared to control.  
In STZ induced diabetic rats, the extract treatment and 
glibenclamide group showed significant decrease 
(p<0.01, p<0.001) in BGL respectively, when com-
pared to diabetic control. 
 
Table 1 Effect of C. pentandra extract on normal rats (single dose study) 
Groups  Treatment & Dose (per 
os) 
Fasting Blood sugar level (mg/dL) at various time intervals 
0 min 30 min 60 min 90 min 120 min 
I Vehicle control 60.67 ± 1.64 63.33 ± 1.25 65.83 ± 1.64 62.83 ± 1.35 29.33 ± 0.66 
II C. pentandra extract 
(200 mg/kg) 
63.00 ± 1.21 69.00 ± 0.77*** 70.83 ± 0.70*** 67.83 ± 0.54** 65.00 ± 1.41 
III C. pentandra extract 
(400 mg/kg) 
64.17 ± 1.10 73.83 ± 0.75*** 71.50 ± 0.71*** 65.67 ± 0.76 62.50 ± 0.99 
IV Glibenclamide (1mg/kg) 62.33 ± 0.73 45.00 ± 0.73*** 42.33 ±0.49*** 43.33 ±0.21*** 41.17 ±0.60*** 
Values are mean ± SEM, (n = 6), ***p<0.001,  **p<0.01.  
Statistically significant p<0.001, p<0.01 compared to 0 min of their respective group. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Table 2 Effect of C. pentandra on OGTT of normal healthy and STZ induced diabetic rats  
Groups  Treatment & Dose 
(p.o.) 
Fasting Blood sugar level (mg/dL) at various time intervals 
0 min 30 min 60 min 90 min 120 min 
I Vehicle control 82.00 ± 1.21 181.20 ± 0.60 175.50 ± 1.40 155.70 ± 1.40 129.3 ± 0.49 
II C. pentandra extract 
(200 mg/kg) 
84.00 ± 0.89 177.50 ± 1.23 165.30 ± 2.12** 140.70 ±1.54*** 119.00 ± 1.25*** 
III Glibenclamide  
(1 mg/kg) 
84.00 ± 0.77 141.2±1.19*** 134.00 ±1.63*** 128.20 ± 1.81*** 97.33 ± 2.216*** 
IV Diabetic control 171.70 ±12.40 472.80 ± 7.43 550.00 ± 0.00 550.00 ± 0.00 550.00 ± 0.00 
V STZ + C. pentandra 
extract (200 mg/kg) 
153.20 ± 6.84 269.30 ± 7.88*** 340.30 ± 9.38*** 393.50 ± 4.22*** 497.00 ± 3.62** 
VI STZ + 
Glibenclamide  
(1 mg/kg) 
169.20 ± 9.69 289.20 ± 7.51*** 388.50 ± 10.50*** 460.00 ± 9.76*** 455.20 ± 10.82*** 
Values are mean ± SEM, (n = 6), ***p<0.001,  **p<0.01.  
Statistically significant p<0.001, p<0.01 compared to their respective control group 
Effect on fasting blood glucose level of STZ induced 
diabetic rats (single dose study) 
The effect of ethanolic extract of C. pentandra on fast-
ing blood sugar level in STZ induced diabetic rats were 
assessed at different time intervals and depicted in Ta-
ble 3. The BGL at different time intervals (30, 60, 90 & 
120 min) were compared with initial (0 min) BGL of 
their respective groups. In diabetic control group there 
was no significant change in BGL during the entire 
study period. The oral administration of Glibenclamide 
to diabetic rats significantly (p<0.001) decreased the 
BGL at different time interval. The extract treatment 
group in STZ induced diabetic rats showed significant 
(p<0.01) decrease in BGL at 90 min when compared to 
initial (0 min) BGL.  
 
Effect on blood glucose level and other parameters of 
STZ induced diabetic rats (repeated dose study) 
Table 4 describes the effect of 21 days long treatment 
with ethanolic extract of C. pentandra on blood glu-
cose level and other parameters of diabetic rats. BGL 
of diabetic control animals was significantly increased 
by 18.62% when compared to normal control animals.  
 
The extract treatment (200 mg/kg) and glibenclamide 
group of diabetic rats showed significant decrease in 
BGL by 31.45% and 28.34%, respectively when com-
pared to diabetic control. Serum insulin level of diabet-
ic control group was significantly decreased by 36.26% 
when compared to normal control group.  
 
The extract treatment and Glibenclamide group of dia-
betic rats increased the serum insulin level by 6.44% 
and 23.70%, respectively. Hepatic glycogen content 
was significantly reduced in diabetic control compared 
to normal control group. The extract treatment and 
glibenclamide group of diabetic rats increased the he-
patic glycogen content (3.98 and 10.29 mg/g, respec-
tively) when compared to diabetic control group (2.50 
mg/g). The total cholesterol level of extract treated 
group was significantly decreased when compared to 
diabetic group whereas the decrease in triglycerides 
level was not significant.  
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Table 3 Effect of C. pentandra extract on STZ induced diabetic rats (single dose study) 
Groups  Treatment & Dose 
(p.o.) 
Fasting Blood sugar level (mg/dL) at various time intervals 
0 min 30 min 60 min 90 min 120 min 
I Diabetic control 340.70±12.23 354.00 ±13.90 357.50 ± 14.06 349.70 ± 11.47 341.00 ± 11.22 
II STZ + C. pentandra 
extract (200 mg/kg) 
348.50 ± 6.05 355.20 ± 5.91 325.70 ± 7.66* 321.20 ± 3.12** 327.30 ± 3.27* 
III STZ + Glibenclamide  
(1 mg/kg) 
342.30 ±1.52 329.20 
±2.38** 
315.80±3.02*** 303.00±2.49*** 295.00±2.67*** 
Values are mean ± SEM, (n = 6), ***p<0.001,  **p<0.01,  *p<0.05 
Statistically significant p<0.001, p<0.01, p<0.05 compared to 0 min of their respective group. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
Table 4 Effect of C. pentandra extract on STZ induced diabetic rats after 21 days treatment 












I Normal control 64.17 ± 1.759 244.20 ± 5.74 4.80 ± 0.19 148.70 ± 2.06 105.7 ± 3.16 
II Diabetic control 502.80 ±19.62*** 
a 
158.60 ± 19.86**a 2.50 ± 0.13* a 241.30±7.8*** a 212.50 ± 5.26** a 
III STZ + C. pentandra 
extract (200 mg/kg) 
318.50 ± 8.7*** b 248.80 ± 4.36** b 3.98 ± 0.57 200.70±3.8*** b 189.30 ± 3.38 
IV STZ + 
Glibenclamide  
(1 mg/kg) 
357.80±28.5*** b 179.80 ± 16.75 10.29 ± 0.66*** b 195.10±4.16*** b 181.40 ± 17.77 
 Values are mean ± SEM, (n = 6), ***p<0.001, **p<0.01, *p<0.05 




Figure 1 Effect of ethanolic bark extract of C. pentan-
dra on STZ-induced liver damage in rats 
 
Figures 1 and 2 depict the effect of ethanolic extract of 
C. pentandra bark on STZ-induced liver and pancreas 
damage in rats. 
 
In the hepatocytes of diabetic group (Figure 1), excess 
vacuolization and granular appearance in the cytoplasm 
and periphery of the nucleus, picnotic nuclei, increased 
sinusoidal spaces, and damage to the central vein with 
moderate infiltration of inflammatory cells were ob-
served. 
 
The pancreas of diabetic group (Figure 2) showed re-
duction in size, scarcity of cells along with degenera-
tion and necrosis, large decrease in endocrine tissue. 
Partly decrease of degenerative cells and the protective 
effect of tissues were noticed in the C. pentandra ex-





Figure 2 The effect of ethanolic bark extract of C. pen-
tandra on STZ-induced pancreatic damage in rats 
 
DISCUSSION 
Diabetes mellitus of long duration is associated with 
several complications such as atherosclerosis, myocar-
dial infarction, neuropathy, nephropathy, etc.  
 
These complications have long been assumed to be 
related to chronically elevated blood glucose levels. 
Diabetes mellitus causes disturbances in the uptake of 
glucose as well as glucose metabolism. STZ-induced 
hyperglycemia has been described as a useful experi-
mental model to study the activity of hypoglycemic 
agents.22  
 
It is known that treatment of rats with high-dose STZ is 
an established model for type 1 diabetes, high-dose of 
STZ severely impairs insulin secretion leading to hy-
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Besides hyperglycemia, STZ-induced diabetic rats also 
shows an important lipolytic activity, due to the insu-
linopenic state which contributes to maintain the ab-
normally elevated plasma triglycerides and cholesterol 
levels.23 The purpose of the present study was to assess 
the effect of ethanolic bark extract of C. pentandra 
therapy on normal and STZ-induced diabetic rats. 
 
The scientific literatures have shown that the root ex-
tracts of C. pentandra possessed hypoglycaemic effect 
and is capable of ameliorating hyperglycaemic in STZ-
induced diabetic rats.14-16 An aqueous bark extract of C. 
pentandra also exhibited hypoglycaemic effect in STZ-
induced diabetic rats.17 From the dry bark of C. pen-
tandra, a new vavain glycoside was isolated in addition 
to known isoflavones, vavain and its glucoside showed 
no activity against α-glucosidase enzyme.18 Our results 
demonstrated that the oral administration of single dose 
of ethanolic extract of C. pentandra bark at two differ-
ent doses (200 and 400 mg/kg) did not significantly 
affect the blood glucose levels in normal rats. 
 
 Treatment with bark extract (200 mg/kg) in STZ-
induced diabetic rats significantly reduced BGL when 
compared to diabetic control. C. pentandra bark extract 
(200 mg/kg) also prevented the rise of blood glucose 
after oral administration of glucose. This could be due 
to an improvement of insulin response to glucose levels 
because the main cause of hyperglycaemia in STZ-
induced diabetic rats appeared to be the lack of re-
sponse of beta-cells to a glucose stimulus. 
 
Thus the extract enhanced glucose utilization and im-
proves glucose tolerance in glucose-loaded rats. The 
long term (21 days) study of ethanolic extract of C. 
pentandra (200 mg/kg) lowered the increased levels of 
blood glucose in STZ-induced diabetic rats. The anti-
hyperglycemic effect of C. pentandra may result from 
the potentiation of insulin from existing  -cells of the 
islets of Langerhans. The blood glucose lowering effect 
was compared with Glibenclamide, a standard hypo-
glycemic drug. Glibenclamide has been used for many 
years to treat diabetes and stimulates insulin secretion 
from pancreatic  -cells.24 
 
The serum insulin level was increased in diabetic rats 
administered Gymnema sylvestre suggesting the insu-
linotropic activity of Gymnema sylvestre leaf extract.25, 
26 This result agrees well with those of the present 
study, when the diabetic animals treated with the etha-
nolic extract of C. pentandra, increased the serum insu-
lin level compared with the diabetic controls. The de-
creased level of tissue glycogen content in diabetic rats 
is probably due to the lack of insulin in the diabetic 
state which results in the inactivation of the glycogen 
synthetase system.27 Administration of C. pentandra 
extract increased the liver glycogen content. Thus pre-
vention of glycogen depletion in the liver might be 
possibly due to stimulation of insulin release from  -
cells, which in turn reactivate the glycogen synthetase 
system. These results are in agreement with other stud-
ies which prevented the depletion in the liver glycogen 
content in alloxan-induced diabetic rabbits by Eugenia 
jambolana.28 
 
High levels of total cholesterol and more importantly 
LDL cholesterol in the blood are major coronary risk 
factors.29 The abnormally high concentration of serum 
lipids in the diabetic condition is due to mainly the 
increase in the mobilization of free fatty acids from the 
peripheral fat depots. Insulin deficiency or insulin re-
sistance may be responsible for dyslipidemia. Oral ad-
ministration of C. pentandra bark extract lowered total 
cholesterol and triglycerides level in diabetic rats when 
compared to diabetic controls. Histopathological stud-
ies have shown that the diabetogenic action of STZ is 
due to specific cytotoxicity actions against hepatocytes 
and pancreatic  -cells. The long term (21 days) treat-
ment of ethanolic bark extract of C. pentandra results 
in partly decrease of degenerative cells and the protec-
tive effect of liver and pancreas against STZ action in 
diabetic rats. 
 
It is concluded that the long term (21 days) administra-
tion of ethanolic extract of C. pentandra bark was ef-
fective in decreasing the blood glucose level and nor-
malizing the other biochemical parameters in diabetic 
rats. The single dose study of the extract has no hypo-
glycemic effect on normal rats. These evidences sug-
gest that the bark of C. pentandra could be beneficial 
for the protection and alleviation of diabetic complica-
tions. Further studies need to be carried out to define 
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